Cassava Sciences | PTIE - Trade Debtors


Cassava Sciences reported $117K in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
Abbott USD 11.22B 655M Mar/2026
Amgen USD 10.23B 1.09B Jun/2026
Biogen USD 1.79B 76.6M Mar/2026
Cara Therapeutics USD 2.24M 2.26M Mar/2025
Cassava Sciences USD 117K 3K Mar/2026
Eisai JPY 253.13B 26.12B Jun/2026
Eli Lilly USD 23.48B 2.3B Jun/2026
Geron USD 44.1M 4.87M Mar/2026
J&J USD 22.54B 1.21B Mar/2026
Merck USD 12.21B 435M Mar/2026
Novartis USD 9.85B 252M Jun/2026
Novavax USD 106.45M 72.27M Dec/2025
Pfizer USD 16.19B 19M Jun/2026
Roche Holding CHF 13.34B 1.44B Jun/2026